[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100475296":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":28,"collaborators":30,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":36,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Nantes University Hospital","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Eric MIRALLIE, PHD","CONTACT","33 2 40 08 31 66","eric.mirallie@chu-nantes.fr",[15],{"facility":5,"status":16,"city":17,"state":18,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":7},"RECRUITING","Nantes","Loire-Atlantique","44093","France","FR",{"type":23,"coordinates":24},"Point",[25,26],-1.55336,47.21725,{"lat":26,"lon":25},{"type":29,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[31],{"name":32,"class":33},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV","100475296","cohort-primary-hyperparathyroidism-100475296",false,"NCT05469087","Cohort Primary Hyperparathyroidism","Prospective Cohort Primary Hyperparathyroidism","CoHPT","Inclusion Criteria:\n\n• Age \\> 18\n\nExclusion Criteria:\n\n* Age \\\u003C 18\n* Pregnancy \u002F lactation\n* Adults underguardianship\n* Secondary\u002Ftertiary hyperparathyroidism\n* Multiple endocrine neoplasia","ALL","18 Years",{"count":45,"type":46},403,"ESTIMATED","OBSERVATIONAL","CoHPT is a prospective, monocentric, observational cohort including all patients diagnosed with primary hyperparathyroidism in Nantes University Hospital, aiming to study the outcomes associated with parathyroidectomy. Clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. A biocollection is collected. The main hypotheses are that parathyroidectomy could improve cardiovascular, renal, bone, and cardiovascular outcomes along with quality of life.",[50],"Primary Hyperparathyroidism",[52,53],"Primary hyperparathyroidism","Parathyroidectomy","2025-08-29",{"date":56,"type":57},"2025-09-08","ACTUAL",{"date":59,"type":57},"2016-03-31",{"date":61,"type":46},"2027-02-24",{"name":5,"class":6},1]